Trials / Completed
CompletedNCT04498078
Creatine Supplementation in Autism Spectrum Disorder
The Effects of Creatine Supplementation in Autism Spectrum Disorder: a Randomized Placebo-controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- University of Novi Sad, Faculty of Sport and Physical Education · Academic / Other
- Sex
- All
- Age
- 10 Years
- Healthy volunteers
- Not accepted
Summary
Autism Spectrum Disorder (ASD) is accompanied by reduced levels of total creatine in right temporal-parietal junction and other brain regions of interest, and addressing this deficit by exogenous administration of creatine may have beneficial effects on brain metabolism and disease-specific clinical symptoms in patients suffering from ASD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Creatine | Creatine monohydrate (20 g per day) |
Timeline
- Start date
- 2022-01-15
- Primary completion
- 2025-05-01
- Completion
- 2025-05-02
- First posted
- 2020-08-04
- Last updated
- 2025-12-22
Locations
1 site across 1 country: Serbia
Source: ClinicalTrials.gov record NCT04498078. Inclusion in this directory is not an endorsement.